SOX9 and acute kidney injury: The mechanism of hAD-MSCs mitigating AKI to CKD progression lied in the exosome shuttling into TECs, thereby activating tubular Sox9, which was reversed by a drug blocking the release of exosomes from hAD-MSCs or a drug inhibiting the expression of Sox9 in TECs.